UK sees a 20% growth in the number of advanced therapy trials, report finds
Cell and Gene Therapy Catapult report also found a surge in the number of commercially sponsored trials
Read More
Tag: Advanced Therapy Medicinal Product
EMA PRIME status granted to Janssen’s inherited retinal disease gene therapy
The designation makes the drug the only XLRP treatment in development to be awarded PRIME designation.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
